ZFIN ID: ZDB-FISH-150901-5990
Fish name: vu19Tg; w9Tg
Genotype: vu19Tg; w9Tg
Targeting Reagent: none
HUMAN DISEASE MODELED by vu19Tg; w9Tg
No data available
GENE EXPRESSION
Gene expression in vu19Tg; w9Tg
RNA expression No data available
Protein expression
Antibody Antigen Genes Structure Conditions Figures
Ab2-adora2a control Fig. 5 with image from Fontenas et al., 2019
PHENOTYPE
Phenotype in vu19Tg; w9Tg
Phenotype Conditions Figures
oligodendrocyte displaced to peripheral nervous system, abnormal chemical treatment by environment: CGS 15943 Fig. 2 with image from Fontenas et al., 2019
oligodendrocyte displaced to motor neuron axon, abnormal chemical treatment by environment: CGS 15943 Fig. 2 with image from Fontenas et al., 2019
oligodendrocyte displaced to motor neuron axon, abnormal chemical treatment by environment: adenosine A2A receptor antagonist Fig. 2 with image from Fontenas et al., 2019
oligodendrocyte displaced to peripheral nervous system, abnormal chemical treatment by environment: adenosine A2A receptor antagonist Fig. 2 with image from Fontenas et al., 2019
oligodendrocyte glial cell migration process quality, abnormal chemical treatment by environment: CGS 15943 Fig. 2 with image from Fontenas et al., 2019
oligodendrocyte glial cell migration process quality, abnormal chemical treatment by environment: adenosine A2A receptor antagonist Fig. 2 with image from Fontenas et al., 2019
peripheral nervous system oligodendrocyte increased amount, abnormal chemical treatment by environment: adenosine A2A receptor antagonist Fig. 2 with image from Fontenas et al., 2019
peripheral nervous system oligodendrocyte increased amount, abnormal chemical treatment by environment: CGS 15943 Fig. 2 with image from Fontenas et al., 2019
peripheral nervous system oligodendrocyte DsRed2 expression mislocalised, abnormal chemical treatment by environment: CGS 15943 Fig. 2 with image from Fontenas et al., 2019
peripheral nervous system oligodendrocyte mislocalised, abnormal chemical treatment by environment: CGS 15943 Fig. 2 with image from Fontenas et al., 2019
peripheral nervous system oligodendrocyte mislocalised, abnormal chemical treatment by environment: adenosine A2A receptor antagonist Fig. 2 with image from Fontenas et al., 2019
peripheral nervous system oligodendrocyte Eos expression mislocalised, abnormal chemical treatment by environment: CGS 15943 Fig. 2 with image from Fontenas et al., 2019

CITATIONS  (3)